Erin Dente

Erin Dente has a diverse work experience spanning over two decades. Erin is currently the Director of Marketing at Texas Health Action, a position they have held since August 2021. Prior to this role, Erin took a hiatus from their career from February 2017 to February 2020 to focus on family care.

Before joining Texas Health Action, Erin worked as a Group Account Director at WCG, a W2O Company, from November 2015 to April 2016. Erin also served as the Director of Enterprise Accounts at iHealth Labs from March 2014 to October 2015. In this role, Erin played a key role in developing and implementing scalable enterprise projects, solidifying partnership agreements with top-tier organizations, and managing the National coverage determination process.

Erin's previous experiences include working as a Sr. Account Director at iCrossing from January 2013 to December 2013, and as an Account Director at Havas Worldwide from 2010 to 2012. Erin has also served as a Patient Marketing Director at Sudler & Hennessey from July 2009 to March 2010, where they drafted a marketing philosophy and strategic approach for patient-specific marketing.

Earlier in their career, Erin worked as a Management Supervisor at R/GA from 2006 to 2009, overseeing the "Clean Home Journal" CRM/Loyalty program for S.C. Johnson. Erin also held positions as an Associate Director of Marketing at Digitas Classic from 2005 to 2006 and as a Management Supervisor at Ogilvy & Mather from September 1999 to August 2005. During their time at Ogilvy & Mather, Erin was responsible for successfully launching ADVAIR and REMICADE brands and managing various high-impact initiatives, including the enrollment of over 100K patients in a CRM program.

Overall, Erin Dente has a strong background in marketing and account management with expertise in strategic planning, partnership development, and project implementation.

Erin Dente graduated from Boston College in 1994, earning a Bachelor of Arts (B.A.) degree with Summa cum Laude honors. There is no specific field of study mentioned.